Given that serum PSA remains the standard biomarker used in clinical practice for the diagnosis of prostate cancer and treatment monitoring in mCRPC patients, we sought to determine if EV-based proteomics identified proteins that correlated with serum PSA levels (Figure 3). This evidence concerns the gene KLK3 and prostate carcinoma.